NDC Package 71993-307-60 Orphenadrine Citrate, Aspirin And Caffeine

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71993-307-60
Package Description:
60 TABLET in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Orphenadrine Citrate, Aspirin And Caffeine
Non-Proprietary Name:
Orphenadrine Citrate, Aspirin And Caffeine
Substance Name:
Aspirin; Caffeine; Orphenadrine Citrate
Usage Information:
Orphenadrine Citrate, Aspirin and Caffeine 50 mg/ 770 mg/ 60 mg Tablets are indicated in:Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.The mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. Orphenadrine Citrate, Aspirin and Caffeine Tablets do not directly relax tense muscles in man.
11-Digit NDC Billing Format:
71993030760
NDC to RxNorm Crosswalk:
  • RxCUI: 994535 - orphenadrine citrate 50 MG / aspirin 770 MG / caffeine 60 MG Oral Tablet
  • RxCUI: 994535 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
  • RxCUI: 994535 - ASA 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Atland Pharmaceuticals, Llc
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Sample Package:
    No
    FDA Application Number:
    ANDA075141
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-01-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71993-307-60?

    The NDC Packaged Code 71993-307-60 is assigned to a package of 60 tablet in 1 bottle, plastic of Orphenadrine Citrate, Aspirin And Caffeine, a human prescription drug labeled by Atland Pharmaceuticals, Llc. The product's dosage form is tablet and is administered via oral form.

    Is NDC 71993-307 included in the NDC Directory?

    Yes, Orphenadrine Citrate, Aspirin And Caffeine with product code 71993-307 is active and included in the NDC Directory. The product was first marketed by Atland Pharmaceuticals, Llc on March 01, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 71993-307-60?

    The 11-digit format is 71993030760. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-271993-307-605-4-271993-0307-60